Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Quoin Pharmaceuticals Ltd. publishes a filing, an earnings call transcript or a press release.

Get QNRX alerts

About Sally Lawlor

Sally Lawlor is recorded as Chief Accounting Officer at Quoin Pharmaceuticals Ltd. (QNRX) since August 18, 2025 and CFO at Quoin Pharmaceuticals Ltd. (QNRX). The newest filing on record that lists Sally Lawlor as CFO at Quoin Pharmaceuticals Ltd. (QNRX) is dated July 16, 2026. Quoin Pharmaceuticals Ltd. reported in an 8-K filed August 21, 2025 that Sally Lawlor was appointed Princial Accounting Officer, effective August 18, 2025. Quoin Pharmaceuticals Ltd. reported in an 8-K filed August 21, 2025 that Sally Lawlor was appointed Chief Financial Officer, effective August 18, 2025. Quoin Pharmaceuticals Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Quoin Pharmaceuticals Ltd. includes Dr. Michael Myers (CEO and Board Member), Denise Carter (COO and Board Member), Dr. Dennis H. Langer (Board Member) and 4 others.

“On August 18, 2025, the Company announced that Sally Lawlor, BCL, FCA has been appointed to serve as the Company's Chief Financial Officer, Principal Financial Officer and Princial Accounting Officer effective as of August 18, 2025 (the "Effective Date").”
Quoin Pharmaceuticals Ltd. Form 8-K, filed August 21, 2025 · Read the filing
“On August 18, 2025, the Company announced that Sally Lawlor, BCL, FCA has been appointed to serve as the Company's Chief Financial Officer, Principal Financial Officer and Princial Accounting Officer effective as of August 18, 2025 (the "Effective Date").”
Quoin Pharmaceuticals Ltd. Form 8-K, filed August 21, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Quoin Pharmaceuticals Ltd.

Recent activity